BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3607785)

  • 21. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse.
    Pavlovsky S; Muriel FS; Eppinger-Helft M; Bustelo P; Garay G; Giuntoli JM; Kvicala R; Divito J; Picón A
    Cancer Treat Rep; 1983 May; 67(5):425-7. PubMed ID: 6573958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
    Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
    Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of combined chemotherapy in treatment-resistant leukaemia of adults (author's transl)].
    Bruntsch U; Osieka R; GAllmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2478-82. PubMed ID: 1059536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V; Kochupillai V
    J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OAP combination in the treatment of elderly leukaemic patients with preexisting severe internal disease.
    Marra R; Pagano L; Liene DR; Storti S; Girasoli M; Leone G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):187-91. PubMed ID: 2475396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["A-Triple-V" treatment of relapsed or refractory acute leukemia].
    Makino S; Araki Y; Tamura K; Seita M
    Rinsho Ketsueki; 1988 Sep; 29(9):1394-8. PubMed ID: 3216510
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
    Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
    Estey E; Thall PF; Pierce S; Kantarjian H; Keating M
    J Clin Oncol; 1997 Feb; 15(2):483-90. PubMed ID: 9053469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination treatment of acute non-lymphocytic leukemia with HOAP and AA--preliminary report of 14 cases].
    Zhang GZ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):52-4. PubMed ID: 1889339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of acute nonlymphoblastic leukemia in childhood: results of protocol ANLL-827 and ANLL-861 studies. Children's Cancer and Leukemia Study Group].
    Yanai M; Tsuji Y; Takeda T; Oka T; Yatabe M; Kikuta A; Kaneko Y; Sekine I; Matsushita T; Utsumi J
    Rinsho Ketsueki; 1987 Oct; 28(10):1754-62. PubMed ID: 3330737
    [No Abstract]   [Full Text] [Related]  

  • 36. [New combination chemotherapy of adult acute nonlymphocytic leukemia].
    Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Nakanishi J; Matsuda T; Natori H; Egami K; Tanaka K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2314-21. PubMed ID: 2937862
    [No Abstract]   [Full Text] [Related]  

  • 37. [Induction and interval treatment of leukemias in children and juveniles].
    Oehme J; Meyer-Beeck D
    Dtsch Med Wochenschr; 1969 Sep; 94(39):1993-6. PubMed ID: 5352272
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric Oncology Group Study of in vitro clonal growth patterns of leukemic cells in childhood acute nonlymphocytic leukemia as a predictor of induction response.
    Findley HW; Steuber CP; Krischer JP; Ragab AH
    Cancer Res; 1987 Aug; 47(15):4225-8. PubMed ID: 3607762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ["B-triple V" therapy as a initial induction treatment of acute leukemias].
    Yokomatsu Y; Sagawa H; Yamane T; Hiyoshi M; Sasaki A; Kishida T; Kojima K; Yoshikawa T; Sannomiya Y; Kawarabayashi K
    Rinsho Ketsueki; 1987 Nov; 28(11):1935-40. PubMed ID: 3446866
    [No Abstract]   [Full Text] [Related]  

  • 40. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
    McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
    Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.